戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 II), and by a decreased urinary excretion of gamma-carboxyglutamic acid.
2 e concomitant conversion of glutamic acid to gamma-carboxyglutamic acid.
3 itamin K-dependent carboxylation to generate gamma-carboxyglutamic acid.
4 translational conversion of glutamic acid to gamma-carboxyglutamic acid, an amino acid critical to th
5 fully carboxylated as demonstrated by direct gamma-carboxyglutamic acid analysis of the alkaline hydr
6                                The auxiliary gamma-carboxyglutamic acid and epidermal growth factor d
7 alcin (ucOC)], plasma phylloquinone, urinary gamma-carboxyglutamic acid, and plasma undercarboxylated
8      The vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid appears to be a highly conser
9 ulation and regulatory proteins that contain gamma-carboxyglutamic acid are a part of a unique class
10 n underestimate of the true contributions of gamma-carboxyglutamic acid at these positions.
11                      Upon binding of Ca2+ to gamma-carboxyglutamic acid, conantokin G undergoes a con
12                            Conantokin G is a gamma-carboxyglutamic acid-containing conotoxin from the
13                           The removal of the gamma-carboxyglutamic acid-containing domain from the fX
14 s transmembrane proteins with amino-terminal gamma-carboxyglutamic acid-containing domains preceded b
15 ions, Ca2+, Mg2+, and Zn2+, to the synthetic gamma-carboxyglutamic acid-containing neuroactive peptid
16 cation, characterization, and structure of a gamma-carboxyglutamic acid-containing peptide, conotoxin
17 ylation system that converts the proteins to gamma-carboxyglutamic acid-containing proteins.
18 its structure to other conotoxins and to the gamma-carboxyglutamic acid-containing regions of the vit
19 sma (IXNP); each protein had the same Mr and gamma-carboxyglutamic acid content.
20                                      Urinary gamma-carboxyglutamic acid did not change in response to
21 e amino-terminus of the Ca(2+)-bound form of gamma-carboxyglutamic acid domain (GD) of human protein
22 I, we expressed wild-type PZ, PZ lacking the gamma-carboxyglutamic acid domain (GD-PZ), and a chimeri
23                  The effect of replacing the gamma-carboxyglutamic acid domain of activated protein C
24                              Deletion of the gamma-carboxyglutamic acid domain of APC, a region criti
25 s like PC/PS vesicles bind to the N-terminal gamma-carboxyglutamic acid domain of APC, and that one m
26 ally inactive and lacks the membrane-binding gamma-carboxyglutamic acid domain of native fXa but reta
27 nic PF4 to the anionic, vitamin K- dependent gamma-carboxyglutamic acid domain of protein C.
28                                          The gamma-carboxyglutamic acid domain substitution therefore
29 constants (Ki) toward a factor IX propeptide/gamma-carboxyglutamic acid domain substrate.
30 d mutagenesis of the 40 N-terminal residues (gamma-carboxyglutamic acid domain) of blood clotting fac
31          Each protein contains an N-terminal gamma-carboxyglutamic acid domain, followed by EGF1 and
32 ates of the protein C derivative lacking the gamma-carboxyglutamic acid domain, which is required for
33                                   Unlike the gamma-carboxyglutamic acid domain-containing proteins of
34 tructure of NAP5 bound at the active site of gamma-carboxyglutamic acid domainless factor Xa (des-fXa
35 -and-tight ligand of the exosites of FXa and gamma-carboxyglutamic acid domainless FXa (des-Gla-FXa),
36 e have constructed a protein C mutant in the gamma-carboxyglutamic acid-domainless form in which the
37 teocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid excretion appear to be sensit
38 n, we report the synthesis of N-alpha-Fmoc-L-gamma-carboxyglutamic acid gamma,gamma'-tert-butyl ester
39 inhibitors of mineralization, such as matrix gamma-carboxyglutamic acid Gla protein, fetuin, and oste
40                                  The missing gamma-carboxyglutamic acid (GLA) and part of epidermal g
41 e carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-depend
42 he independent importance of the propeptide, gamma-carboxyglutamic acid (Gla) domain and elements bey
43 ey are bound, multiple glutamic acids in the gamma-carboxyglutamic acid (Gla) domain are carboxylated
44                                   First, the gamma-carboxyglutamic acid (Gla) domain binds C6PS only
45  stimulatory effect requires presence of the gamma-carboxyglutamic acid (Gla) domain in protein C and
46 uivalent in terms of the manner in which the gamma-carboxyglutamic acid (Gla) domain of each protein
47                       The glutamic acid-rich gamma-carboxyglutamic acid (Gla) domain of factor IX is
48                           Similar to FX, the gamma-carboxyglutamic acid (Gla) domain of FII binds wit
49 othelial cells and that its occupancy by the gamma-carboxyglutamic acid (Gla) domain of protein C/APC
50                      Residue K5 in factor IX gamma-carboxyglutamic acid (Gla) domain participates in
51 +)), have three of seven Ca(2+) sites in the gamma-carboxyglutamic acid (Gla) domain replaced by Mg(2
52 hain of factor X consists of an NH2-terminal gamma-carboxyglutamic acid (Gla) domain, followed by a f
53 loop Lys159-Lys165, are near the factor VIIa gamma-carboxyglutamic acid (Gla) domain, suggesting that
54            Factor VIIa (FVIIa) consists of a gamma-carboxyglutamic acid (Gla) domain, two epidermal g
55 helial protein C receptor (EPCR) through its gamma-carboxyglutamic acid (Gla) domain, with unknown he
56                         Four of these encode gamma-carboxyglutamic acid (Gla) domain-containing prote
57  (PC) rely on the presence of the N-terminal gamma-carboxyglutamic acid (Gla) domain.
58 acids (G4-Q11) exposed on the surface of the gamma-carboxyglutamic acid (Gla) domain.
59 ranes containing phosphatidylserine (PS) via gamma-carboxyglutamic acid (Gla) domains is one of the e
60 nhanced function requires interaction of the gamma-carboxyglutamic acid (Gla) domains of factor IXa a
61                        To assess the role of gamma-carboxyglutamic acid (Gla) domains of FX and FIX i
62 ranes containing phosphatidylserine (PS) via gamma-carboxyglutamic acid (Gla) domains.
63 mic acids on these proteins are converted to gamma-carboxyglutamic acid (Gla) in a reaction that requ
64 rage tumor acidity, and replacing Asp14 with gamma-carboxyglutamic acid (Gla) increases the sharpness
65                                            L-gamma-Carboxyglutamic acid (Gla) is an uncommon amino ac
66 ovel membrane proteins have an extracellular gamma-carboxyglutamic acid (Gla) protein domain and cyto
67                             The proline-rich gamma-carboxyglutamic acid (Gla) proteins (PRGPs) 1 and
68 s one of four known vertebrate transmembrane gamma-carboxyglutamic acid (Gla) proteins.
69       We investigated the functional role of gamma-carboxyglutamic acid (Gla) residue 21 of human fac
70 s property seemed to correlate with an extra gamma-carboxyglutamic acid (Gla) residue at position 11
71  The 17-residue peptide, which contains five gamma-carboxyglutamic acid (Gla) residues and an amidate
72 gely governed by the periodic positioning of gamma-carboxyglutamic acid (Gla) residues within the pri
73 tidine within the intercysteine-loop and two gamma-carboxyglutamic acid (Gla) residues, formed by pos
74 idue polypeptide containing five residues of gamma-carboxyglutamic acid (Gla), and conantokin-T (con-
75 aturally occurring amino acid analogues of l-gamma-carboxyglutamic acid (Gla), appropriately protecte
76  the x-ray crystallographic structure of the gamma-carboxyglutamic acid (Gla)-domainless activated fo
77  reacts with CO(2) and glutamate to generate gamma-carboxyglutamic acid (Gla).
78 mily have glutamic acid residues modified to gamma-carboxyglutamic acids (Gla) by a specific gamma-ca
79 P4 and BMP9 and their inhibitors MGP (matrix gamma-carboxyglutamic acid [Gla] protein) and CV2 (cross
80                            Conantokin G is a gamma-carboxyglutamic acid- (Gla-) containing conotoxin
81 min K-dependent carboxylase and its product, gamma-carboxyglutamic acid, have been identified.
82 translational conversion of glutamic acid to gamma-carboxyglutamic acid in precursor proteins contain
83 arboxylated osteocalcin (%ucOC), and urinary gamma-carboxyglutamic acid in response to 5 d of supplem
84                   To investigate the role of gamma-carboxyglutamic acid in the calcium-induced struct
85             To gain insight into the role of gamma-carboxyglutamic acid in the structure of this pept
86 anslational modification of glutamic acid to gamma-carboxyglutamic acid in the vitamin K-dependent pr
87 doplasmic reticulum membrane responsible for gamma-carboxyglutamic acid modification of vitamin K-dep
88 boxylation system with enhanced capacity for gamma-carboxyglutamic acid modification.
89                                       Matrix gamma-carboxyglutamic acid protein (MGP) is a member of
90                                       Matrix gamma-carboxyglutamic acid protein (MGP) is a mineral-bi
91  fibrosis and calcification and found matrix gamma-carboxyglutamic acid protein, decorin, periostin,
92 gen production and gene expression of matrix gamma-carboxyglutamic acid protein, recently shown to pl
93 a substitution based on the sequence in bone gamma-carboxyglutamic acid protein.
94 ing a family of proteins termed proline-rich gamma-carboxyglutamic acid (PRRG) proteins were identifi
95 thesis that stapling can effectively replace gamma-carboxyglutamic acid residues in stabilizing the h
96 tive patch created by the side chains of two gamma-carboxyglutamic acid residues that extend outward
97                       These peptides contain gamma-carboxyglutamic acid residues typically spaced at
98 dified residues: four cysteine residues, two gamma-carboxyglutamic acid residues, and one residue eac
99  17-residue polypeptide, which contains five gamma-carboxyglutamic acid residues, is a N-methyl-d-asp
100 ogen factor X as well as derivatives lacking gamma-carboxyglutamic acid residues.
101 -PAGE, active site titration, and content of gamma-carboxyglutamic acid residues.
102 fies precursors of these proteins to contain gamma-carboxyglutamic acid residues.
103 pancy of the metal binding sites, defined by gamma-carboxyglutamic acids, results in formation of a c
104 rginine substitution at amino acid 12 in the gamma-carboxyglutamic acid rich (Gla) domain of the matu
105 ydrophobic omega-loop within the prothrombin gamma-carboxyglutamic acid-rich (Gla) domain is importan
106  stabilize the structural orientation of the gamma-carboxyglutamic acid-rich (Gla) domain relative to
107 od coagulation is mediated by the N-terminal gamma-carboxyglutamic acid-rich (Gla) domain, a membrane
108   This binding is mediated by the n-terminal gamma-carboxyglutamic acid-rich domain of this protein.
109  particular interest are the interactions of gamma-carboxyglutamic acid-rich domain-containing clotti
110 compared with individual modules because the gamma-carboxyglutamic acid-rich module and the thrombin-
111  a designed "microprotein S," comprising the gamma-carboxyglutamic acid-rich module, the thrombin-sen
112 heral proteins by using the membrane anchor (gamma-carboxyglutamic-acid-rich domain; GLA domain) of h
113  across animal species and the importance of gamma-carboxyglutamic acid synthesis in diverse biologic
114           Twenty-four-hour ratios of urinary gamma-carboxyglutamic acid to creatinine were unchanged
115               To examine its biosynthesis of gamma-carboxyglutamic acid, we studied the carboxylase f
116 oute for the preparation of Fmoc-protected l-gamma-carboxyglutamic acid, which is amenable to large-s
117 this reaction, glutamic acid is converted to gamma-carboxyglutamic acid while vitamin KH2 is converte

 
Page Top